中银港股通医药混合发起C(020398)资产负债表
| |
2025-06-30 |
2024-12-31 |
2024-06-30 |
| 资产 |
| 银行存款 |
- |
- |
- |
| 结算备付金 |
24,004,538.07 |
454,271.92 |
14,253.49 |
| 存出保证金 |
2,124,993.44 |
9,138.25 |
4,108.45 |
| 交易性金融资产 |
724,087,635.77 |
103,759,078.38 |
54,997,719.46 |
| 其中：股票投资 |
686,450,736.59 |
98,112,689.78 |
51,755,770.53 |
| 债券投资 |
37,636,899.18 |
5,646,388.60 |
3,241,948.93 |
| 资产支持证券投资 |
- |
- |
- |
| 衍生金融资产 |
- |
- |
- |
| 买入返售金融资产 |
- |
- |
- |
| 应收证券清算款 |
- |
- |
- |
| 应收利息 |
- |
- |
- |
| 应收股利 |
373,762.30 |
- |
55,969.11 |
| 应收申购款 |
37,442,062.43 |
798,177.82 |
306,837.59 |
| 其他资产 |
- |
- |
- |
| 资产总计 |
849,325,186.42 |
111,997,705.53 |
57,013,575.91 |
| 负 债 |
| 短期借款 |
- |
- |
- |
| 交易性金融负债 |
- |
- |
- |
| 衍生金融负债 |
- |
- |
- |
| 卖出回购金融资产款 |
- |
- |
- |
| 应付证券清算款 |
36,421,336.56 |
3,834,493.97 |
10.70 |
| 应付赎回款 |
71,401,967.68 |
1,361,190.73 |
1,297,907.72 |
| 应付管理人报酬 |
527,992.19 |
107,521.07 |
59,184.31 |
| 应付托管费 |
87,998.70 |
17,920.20 |
9,864.05 |
| 应付销售服务费 |
140,521.47 |
25,240.01 |
9,956.40 |
| 应付交易费用 |
- |
- |
- |
| 应交税费 |
- |
- |
- |
| 应付利息 |
- |
- |
- |
| 应付利润 |
- |
- |
- |
| 其他负债 |
388,596.36 |
152,187.96 |
105,431.93 |
| 负债合计 |
108,968,412.96 |
5,498,553.94 |
1,482,355.11 |
| 所有者权益 |
| 实收基金 |
497,300,239.82 |
121,205,987.42 |
68,122,240.99 |
| 未分配利润 |
243,056,533.64 |
-14,706,835.83 |
-12,591,020.19 |
| 所有者权益合计 |
740,356,773.46 |
106,499,151.59 |
55,531,220.80 |
| 负债及所有者权益总计 |
849,325,186.42 |
111,997,705.53 |
57,013,575.91 |
微信公众号
证券之星APP
基本资料
